Press Release: Edgemont Pharmaceuticals : Market Report, "Edgemont Pharmaceuticals, LLC - Pharmaceuticals & Healthcare - Deals and Alliances Profile", published

(PR-inside.com) Summary Edgemont Pharmaceuticals, LLC (Edgemont) is a pharmaceutical company. The company develops novel drug formulations and therapies in the field of neuroscience. Its marketed products include Forfivo XL and Fluoxetine Tablets. Edgemont's Forfivo XL 450 mg is indicated for the treatment of major depressive disorder; and Fluoxetine Tablets 60 mg is indicated for the treatment of major depressive disorder, bulimia nervosa, obsessive-compulsive disorder, and panic disorder in adults. The company's products include EDG004 for general anxiety disorder, EDG005 for major depressive disorder, EDG006 for treatment resistant depression, EDG007 for menopausal vasomotor symptoms and EDG008 for general anxiety disorder. It offers its ..